Canadian Diabetes Association Clinical Practice Guidelines 2013. Can J Diabetes2013;37:S142-4.
2.
BoultonAJVinikAIArezzoJC. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care2005;28:956-62.
3.
HermanWHKennedyL.Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care2005;28:1480-1.
4.
AbrahamRMAbrahamRR.Absence of the sensory action potential of the medial plantar nerve: a sensitive indicator of diabetes neuropathy. Diabet Med1987;4:469-74.
5.
PerkinsBAGrewalJNgE. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care2006;9:2023-7.
6.
KongXLesserEAGozaniSN.Repeatability of nerve conduction measurements derived entirely by computer methods. Biomed Eng Online2009;8:33.
7.
BurkeDSkuseNFLethleanAK.Sensory conduction of the sural nerve in polyneuropathy. J Neurol Neurosurg Psychiatry1974;37:647-52.
8.
DyckPJKarnesJLDaubeJ. Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain1985;108(Pt 4):861-80.
9.
Calles-EscandonJLovatoLCSimons-MortonDG. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care2010;33:721-7.
10.
JohnstonMVPogachLRajanM. Personal and treatment factors associated with foot self-care among veterans with diabetes. J Rehabil Res Dev2006;43:227-38.
11.
Scollan-KoliopoulosMWalkerEABleichD.Perceived risk of amputation, emotions, and foot self-care among adults with type 2 diabetes. Diabetes Educ2010;36:473-82.
